Basilea's sales double and loss narrows
18 August 2009
Sita Shah
Please Login to read the full article.
18 August 2009
Sita Shah
sita.shah@informa.com
Basilea Pharmaceutica's sales more than doubled to CHF12.2 million ($11.4 million) in the first half and its net loss narrowed by 2% to CHF66.5 million.
Sales were ahead of the consensus estimate of CHF10 million, boosted by up-front payments from Johnson & Johnson for Zeftera/Zevtera (ceftobiprole...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Austerity takes off gloss from Basilea's Toctino forecasts
- Pfizer's combined anti-fungals fails to beat Vfend alone in aspergillosis
- Amgen/Takeda's $0-rated motesanib fails Phase III lung cancer trial
- Alkermes' PhII ALKS-5461: new mechanism, opiate receptor modulation, for refractory depression
COMMENT
Other Informa Comment
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
